News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gottesdiener Keith Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 8,111 shares
@ $0
Granted 12,547 options to buy
@ $9.17, valued at
$115.1k
|
|
| 04/04/2023 |
4
| Gottesdiener Keith Michael (See Remarks) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 497,738 options to buy
@ $12.3, valued at
$6.1M
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,595 shares
@ $0
Granted 2,966 options to buy
@ $72.74, valued at
$215.7k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 33,072 options to buy
@ $4.59, valued at
$151.8k
|
|
| 07/17/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 7,500 options to buy
@ $4.59, valued at
$34.4k
|
|
| 06/21/2019 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,570 shares
@ $0
Granted 2,174 options to buy
@ $82.25, valued at
$178.8k
|
|
| 03/19/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 7,961 shares
@ $30.04, valued at
$239.1k
Sold 2,329 shares
@ $30.27, valued at
$70.5k
|
|
| 03/15/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 7,782 shares
@ $30.06, valued at
$233.9k
Sold 1,506 shares
@ $30.05, valued at
$45.3k
|
|
| 02/28/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 635 shares
@ $30.13, valued at
$19.1k
Sold 1,814 shares
@ $30.01, valued at
$54.4k
|
|
| 02/20/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 12,002 shares
@ $30.02, valued at
$360.3k
Sold 918 shares
@ $30.05, valued at
$27.6k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 15,674 shares
@ $30.05, valued at
$471k
Sold 105 shares
@ $30.21, valued at
$3.2k
|
|
| 01/22/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 10,115 shares
@ $30.01, valued at
$303.6k
|
|
| 01/17/2019 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 662 shares
@ $30, valued at
$19.9k
|
|
| 12/06/2018 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 563 shares
@ $30, valued at
$16.9k
|
|
| 11/06/2018 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 16,500 shares
@ $30.08, valued at
$496.3k
|
|
| 06/22/2018 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,787 shares
@ $0
Granted 2,748 options to buy
@ $85.12, valued at
$233.9k
|
|
| 05/10/2018 |
4
| Gottesdiener Keith Michael (C.E.O. and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,000 options to buy
@ $4.59, valued at
$13.8k
|
|
| 04/09/2018 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Bought 1,171 shares
@ $64, valued at
$74.9k
|
|
| 02/16/2018 |
4
| Gottesdiener Keith Michael (CEO & President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 175,000 options to buy
@ $25.79, valued at
$4.5M
|
|
| 10/10/2017 |
4
| Gottesdiener Keith Michael (CEO and President) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Converted 27,262 shares
@ $0
Converted 27,262 convertible preferred
@ $0 |
|
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/21/2016 |
4
| Gottesdiener Keith Michael (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 2,407 shares
@ $0
Granted 3,196 options to buy
@ $145.22, valued at
$464.1k
|
|
|
|